ioflupane   Click here for help

GtoPdb Ligand ID: 7653

Synonyms: 123I-FP-CIT | 123I-ioflupane | DaTSCAN®
Approved drug
ioflupane is an approved drug (EMA (2000), FDA (2011))
Compound class: Synthetic organic
Comment: This compound is represented on ChEMBL with slightly different stereochemistry by CHEMBL2096623.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: vilanterol

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 6
Topological polar surface area 29.54
Molecular weight 431.08
XLogP 4.31
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FCCCN1C2CCC1C(C(C2)c1ccc(cc1)I)C(=O)OC
Isomeric SMILES FCCCN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)c1ccc(cc1)[123I])C(=O)OC
InChI InChI=1S/C18H23FINO2/c1-23-18(22)17-15(12-3-5-13(20)6-4-12)11-14-7-8-16(17)21(14)10-2-9-19/h3-6,14-17H,2,7-11H2,1H3/t14-,15+,16+,17-/m0/s1/i20-4
InChI Key HXWLAJVUJSVENX-HFIFKADTSA-N
No information available.
Summary of Clinical Use Click here for help
Ioflupane is a radiopharmaceutical drug. It is used for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging, for the diagnosis/differential diagnosis of Parkinson's disease [1-2], and diagnosis of dementia with Lewy bodies [3].
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Ioflupane binds to dopamine transporters. As these are diminished in Parkinson's disease, the pattern of binding in the striatum is abnormal and is diagnostic of the disease.
External links Click here for help